Ace Vision Group
Ace Vision Group, Inc. (AVG) is an emerging ophthalmic laser device company dedicated to bringing touchless eye laser therapy to patients suffering from age-related vision loss. The company is pioneering a new rejuvenation therapy for the aging eye, focusing on innovative therapeutics and minimally invasive procedures such as Laser Scleral Microporation (LSM). Their mission is to develop solutions that address the biomechanical dysfunction of the eye associated with presbyopia and other age-related ocular conditions, aiming to improve patients' quality of life through advanced, non-invasive treatments.
Industries
Nr. of Employees
small (1-50)
Ace Vision Group
Patents
Ocular simulated camera assisted robot for live, virtual or remote eye surgery training apparatus and method
US-12300119-B2
View DetailsSystem and methods using real-time predictive virtual 3D eye finite element modeling for simulation of ocular structure biomechanics
US-12285212-B2
View DetailsSystems and methods for affecting the biomechanical properties of connective tissue
US-12036150-B2
View DetailsSystem and methods using real-time predictive virtual 3D eye finite element modeling for simulation of ocular structure biomechanics
US-11844570-B2
View DetailsSystem and methods using real-time predictive virtual 3D eye finite element modeling for simulation of ocular structure biomechanics
US-11071450-B2
View Details
Ocular simulated camera assisted robot for live, virtual or remote eye surgery training apparatus and method
US-12300119-B2
View DetailsSystem and methods using real-time predictive virtual 3D eye finite element modeling for simulation of ocular structure biomechanics
US-12285212-B2
View DetailsSystems and methods for affecting the biomechanical properties of connective tissue
US-12036150-B2
View DetailsSystem and methods using real-time predictive virtual 3D eye finite element modeling for simulation of ocular structure biomechanics
US-11844570-B2
View DetailsSystem and methods using real-time predictive virtual 3D eye finite element modeling for simulation of ocular structure biomechanics
US-11071450-B2
View DetailsProducts
Ophthalmic laser system for touchless microporation
A laser platform engineered to deliver arrays of micropores to the sclera in a touchless manner to alter scleral biomechanics for presbyopia treatment; currently in clinical evaluation.
AI-driven virtual eye simulation platform
Software platform implementing a digital twin of the eye to model aging, lens and biomechanical changes, and to assist in treatment planning and outcome prediction.
VisioLite
An ophthalmic Er:YAG laser system developed by Ace Vision Group for performing laser scleral microporation (LSM) to treat progressive presbyopia.
VisioLite® Er. YAG Laser System Alpha 2.0 Configuration
An advanced Er:YAG laser system evaluated in the Alpha 2.0 configuration, currently under development.
Ophthalmic laser system for touchless microporation
A laser platform engineered to deliver arrays of micropores to the sclera in a touchless manner to alter scleral biomechanics for presbyopia treatment; currently in clinical evaluation.
AI-driven virtual eye simulation platform
Software platform implementing a digital twin of the eye to model aging, lens and biomechanical changes, and to assist in treatment planning and outcome prediction.
VisioLite
An ophthalmic Er:YAG laser system developed by Ace Vision Group for performing laser scleral microporation (LSM) to treat progressive presbyopia.
VisioLite® Er. YAG Laser System Alpha 2.0 Configuration
An advanced Er:YAG laser system evaluated in the Alpha 2.0 configuration, currently under development.
Services
Support for recruiting and coordinating multi‑site clinical research outside the United States for investigational ophthalmic therapies.
Training and educational programs for eye care providers on performing touchless scleral microporation procedures and associated clinical workflows.
AI-enabled virtual eye simulation for modeling aging and personalizing presbyopia treatment strategies.
Support for recruiting and coordinating multi‑site clinical research outside the United States for investigational ophthalmic therapies.
Training and educational programs for eye care providers on performing touchless scleral microporation procedures and associated clinical workflows.
AI-enabled virtual eye simulation for modeling aging and personalizing presbyopia treatment strategies.
Expertise Areas
- Clinical trial management for ophthalmic devices
- Ophthalmic laser device engineering
- Presbyopia therapeutics and scleral interventions
- Ocular biomechanics and kinematic modeling
Key Technologies
- Laser-based scleral microporation
- Ophthalmic laser systems
- AI-driven digital twin
- Virtual reality simulation
News & Updates
Dr. Lin’s expertise in refractive lasers and medical devices will help drive device development. He was appointed as Chief Medical Advisor.
Ace Vision Group announced the successful close of a $29.4 million Series B financing round to support its laser microporation therapy.
The company will host an event and scientific presentations at the 2025 ASCRS Annual Meeting.
Study results show high satisfaction and safety in presbyopic patients treated with laser scleral microporation.
Discussion of laser scleral microporation as a treatment for presbyopia that does not interfere with the visual axis.
Dr. Lin’s expertise in refractive lasers and medical devices will help drive device development. He was appointed as Chief Medical Advisor.
Dr. Lin’s expertise in refractive lasers and medical devices will help drive device development. He was appointed as Chief Medical Advisor.
Ace Vision Group announced the successful close of a $29.4 million Series B financing round to support its laser microporation therapy.
The company will host an event and scientific presentations at the 2025 ASCRS Annual Meeting.
Study results show high satisfaction and safety in presbyopic patients treated with laser scleral microporation.
Discussion of laser scleral microporation as a treatment for presbyopia that does not interfere with the visual axis.
Dr. Lin’s expertise in refractive lasers and medical devices will help drive device development. He was appointed as Chief Medical Advisor.